Fresh Tracks Therapeutics, Inc.
FRTX
Price:
$0.935
Market Cap:
$5.59M
Fresh Tracks Therapeutics, Inc. is a clinical-stage pharmaceutical firm focused on creating diverse prescription therapies to address a range of severe autoimmune, inflammatory, and other chronic debilitating conditions, primarily within the U.S. market. A key compound in its development pipeline is sofpironium bromide, which has successfully completed Phase III clinical trials for the management of primary axillary hyperhidrosis. The company is also advancing BBI-02, an oral DYRK1A inhibitor targeting autoimmune and inflammatory diseases, and BBI-10, a covalent STING pathway inhibitor with potential for treating autoinflammatory and rare genetic disorders. Furthermore, Fresh Tracks is engag...[Read more]
Industry
Biotechnology
IPO Date
1993-03-10
Stock Exchange
NASDAQ
Ticker
FRTX
PE Ratio
[-0.88]
ROE
[-66.50%]
Current Ratio
[6.98]
Dividend Yield
[0%]
Enterprise Value
[-5282955.00]
Dividend History
The ROE as of June 2026 (TTM) for Fresh Tracks Therapeutics, Inc. (FRTX) is -66.50%
According to Fresh Tracks Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -66.50%. This represents a change of 312.16% compared to the average of -16.14% of the last 4 quarters.
Fresh Tracks Therapeutics, Inc. (FRTX) Historical ROE (quarterly & annually)
How has FRTX ROE performed in the past?
The mean historical ROE of Fresh Tracks Therapeutics, Inc. over the last ten years is -104.85%. The current -66.50% ROE has changed -36.57% with respect to the historical average. Over the past ten years (40 quarters), FRTX's ROE was at its highest in in the September 2023 quarter at 19.22%. The ROE was at its lowest in in the December 2019 quarter at -143.41%.
Average
-104.85%
Median
-45.34%
Minimum
-342.55%
Maximum
-19.88%
Fresh Tracks Therapeutics, Inc. (FRTX) ROE by Quarter and Year
Discovering the peaks and valleys of Fresh Tracks Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 927.68%
Maximum Annual ROE = -19.88%
Minimum Annual Increase = -80.03%
Minimum Annual ROE = -342.55%
| Year | ROE | Change |
|---|---|---|
| 2023 | -57.34% | -80.03% |
| 2022 | -287.20% | 81.00% |
| 2021 | -158.67% | 105.98% |
| 2020 | -77.03% | -77.51% |
| 2019 | -342.55% | 927.68% |
| 2018 | -33.33% | 63.52% |
| 2017 | -20.38% | 2.55% |
| 2016 | -19.88% | -2.32% |
| 2015 | -20.35% | -35.93% |
| 2014 | -31.76% | -37.56% |
Fresh Tracks Therapeutics, Inc. (FRTX) Average ROE
How has FRTX ROE performed in the past?
The current ROE of Fresh Tracks Therapeutics, Inc. (FRTX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-167.74%
5-year avg
-184.56%
10-year avg
-104.85%
Fresh Tracks Therapeutics, Inc. (FRTX) ROE vs. Peers
How is FRTX’s ROE compared to its peers?
Fresh Tracks Therapeutics, Inc.’s ROE is greater than Entero Therapeutics, Inc. (-18.69%), greater than BiondVax Pharmaceuticals Ltd. (-4.92%), greater than Tricida, Inc. (-355.98%), greater than Tectonic Therapeutic, Inc. (-32.33%), less than Longevity Health Holdings Inc. (133.44%), greater than Xenetic Biosciences, Inc. (-39.28%), greater than Neuphoria Therapeutics Inc. (-109.66%), greater than Nabriva Therapeutics plc (-201.91%), greater than Aptose Biosciences Inc. (-23.18%), greater than TNF Pharmaceuticals, Inc. (-59.95%),
| Company | ROE | Market cap |
|---|---|---|
| -18.69% | $13.58M | |
| -4.92% | $4.97M | |
| -355.98% | $5.95M | |
| -32.33% | $571.36M | |
| 133.44% | $373.13K | |
| -39.28% | $6.04M | |
| -109.66% | $23.62M | |
| -201.91% | $323.00 | |
| -23.18% | $4.36M | |
| -59.95% | $9.18M |
Build a custom stock screener for Fresh Tracks Therapeutics, Inc. (FRTX) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Fresh Tracks Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Fresh Tracks Therapeutics, Inc. (FRTX) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Fresh Tracks Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Fresh Tracks Therapeutics, Inc.'s ROE?
How is the ROE calculated for Fresh Tracks Therapeutics, Inc. (FRTX)?
What is the highest ROE for Fresh Tracks Therapeutics, Inc. (FRTX)?
What is the 3-year average ROE for Fresh Tracks Therapeutics, Inc. (FRTX)?
What is the 5-year average ROE for Fresh Tracks Therapeutics, Inc. (FRTX)?
How does the current ROE for Fresh Tracks Therapeutics, Inc. (FRTX) compare to its historical average?